NEW YORK (GenomeWeb News) – The neuropsychiatric personalized medicine company Genomind has selected DNA Genotek's Oragene DNA sample collection kit for use in its Genecept Mood Assay, DNA Genotek announced today.
Using DNA found in saliva samples, the Genomind Genecept Mood Assay assesses polymorphisms in genes related to neurotransmitter function and drug metabolism to provide insights for physicians treating individuals with certain psychiatric conditions.
The personalized genetic test, which is prescribed by physicians, is intended to provide genotypic information that may be useful for gauging an individual's response to specific medications and guiding treatment.
Once the Oragene DNA kit is used to collect saliva samples, these samples are sent to the Genomind lab, where the genetic analyses are done. An analytical report that outlines and interprets the results of these tests is then sent to the patient's physician via a secure website.
"Genomind’s selection of the Oragene DNA product is another exciting validation of our work to deliver high-quality, non-invasive sample collection devices for personalized medicine applications such as behavioral health," DNA Genotek CEO Ian Curry said in a statement.
DNA Genotek filed for US Food and Drug Administration clearance for its Oragene Dx products last month.